Guardant Health

Strategic Collaboration to Study Liquid Biopsy in Spain

Back to NEWS
Guardant Health Picture

“Guardant360 has already helped thousands of patients avoid the costs, complications and delays of invasive biopsy procedures,” said Helmy Eltoukhy, Guardant Health CEO. “Pangaea and MedSIR have strong track records in clinical trial design and execution in Spain and are ideal partners for Guardant Health.” – Source Guardant Health

Please check the article on Guardant Health Website

Share (and comment) this content

Back to NEWS